Clinical Trial Update: Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in Infants [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Eupolio (IPV) for safety, long-term protection, and booster effects in primary vaccination schedules, including a schedule with bival…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Eupolio (inactivated poliovirus vaccine)

Snippet

Sponsor: LG Chem | Conditions: Poliomyelitis, Vaccine Reaction | Phase 3 | Status: COMPLETED